Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial
Top Cited Papers
- 1 October 2004
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 364 (9443) , 1411-1420
- https://doi.org/10.1016/s0140-6736(04)17223-1
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- An attack on all frontsNature, 2004
- UPDATE ON THE CLINICAL DEVELOPMENT OF CANDIDATE MALARIA VACCINESThe American Journal of Tropical Medicine and Hygiene, 2004
- The global distribution and population at risk of malaria: past, present, and futureThe Lancet Infectious Diseases, 2004
- Epidemiology and clinical presentation of respiratory syncytial virus infection in a rural area of southern MozambiqueThe Pediatric Infectious Disease Journal, 2002
- Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trialThe Lancet, 2001
- Efficacy of Recombinant Circumsporozoite Protein Vaccine Regimens against ExperimentalPlasmodium falciparumMalariaThe Journal of Infectious Diseases, 2001
- A phase I safety and immunogenicity trial with the candidate malaria vaccine RTS,S/SBAS2 in semi-immune adults in The Gambia.The American Journal of Tropical Medicine and Hygiene, 1999
- A Preliminary Evaluation of a Recombinant Circumsporozoite Protein Vaccine againstPlasmodium falciparumMalariaNew England Journal of Medicine, 1997
- Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern TanzaniaThe Lancet, 1994
- DNA Cloning of Plasmodium falciparum Circumsporozoite Gene: Amino Acid Sequence of Repetitive EpitopeScience, 1984